Skip to content
2000
Volume 20, Issue 3
  • ISSN: 1573-4080
  • E-ISSN:
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journals/cei/10.2174/0115734080298673240424052128
2024-10-01
2024-11-16
Loading full text...

Full text loading...

References

  1. LopezJ.A. SusantoO. JenkinsM.R. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.Blood2013121142659266810.1182/blood‑2012‑07‑446146 23377437
    [Google Scholar]
  2. SekoY. ShinkaiY. KawasakiA. YagitaH. OkumuraK. YazakiY. Evidence of perforin‐mediated cardiac myocyte injury in acute murine myocarditis caused by coxsackie virus B3.J. Pathol.19931701535810.1002/path.1711700109 8392106
    [Google Scholar]
  3. NovaisF.O. CarvalhoL.P. GraffJ.W. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis.PLoS Pathog.201397e100350410.1371/journal.ppat.1003504 23874205
    [Google Scholar]
  4. SpicerJ.A. HuttunenK.M. JoseJ. Small molecule inhibitors of lymphocyte perforin as focused immunosuppressants for infection and autoimmunity.J. Med. Chem.20226521143051432510.1021/acs.jmedchem.2c01338 36263926
    [Google Scholar]
  5. WelzM. EickhoffS. AbdullahZ. Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis.Nat. Commun.201891480510.1038/s41467‑018‑07213‑x 30442932
    [Google Scholar]
  6. Gonzalez-FierroC. FonteC. DufourdE. Effects of a small-molecule perforin inhibitor in a mouse model of CD8 T cell–mediated neuroinflammation.Neurol. Neuroimmunol. Neuroinflamm.2023104e20011710.1212/NXI.0000000000200117 37080596
    [Google Scholar]
  7. GartlanK.H. JaiswalJ.K. BullM.R. Preclinical activity and pharmacokinetic/pharmacodynamic relationship for a series of novel benzenesulfonamide perforin inhibitors.ACS Pharmacol. Transl. Sci.20225642943910.1021/acsptsci.2c00009 35711815
    [Google Scholar]
  8. GyntherM. PickeringD.S. SpicerJ.A. DennyW.A. HuttunenK.M. Systemic and brain pharmacokinetics of perforin inhibitor prodrugs.Mol. Pharm.20161372484249110.1021/acs.molpharmaceut.6b00217 27266990
    [Google Scholar]
  9. JoseJ. LawR.H.P. LeungE.W.W. Fragment-based and structure-guided discovery of perforin inhibitors.Eur. J. Med. Chem.202326111578610.1016/j.ejmech.2023.115786 37716187
    [Google Scholar]
  10. YagitaM. HuangC.L. UmeharaH. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.Leukemia200014592293010.1038/sj.leu.2401769 10803526
    [Google Scholar]
  11. KleinE. VánkyF. Ben-BassatH. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia.Int. J. Cancer197618442143110.1002/ijc.2910180405 789258
    [Google Scholar]
  12. TampioJ. HuttunenJ. MontaserA. HuttunenK.M. Targeting of perforin inhibitor into the brain parenchyma via a prodrug approach can decrease oxidative stress and neuroinflammation and improve cell survival.Mol. Neurobiol.202057114563457710.1007/s12035‑020‑02045‑7 32754897
    [Google Scholar]
  13. SpicerJ.A. LenaG. LyonsD.M. Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin.J. Med. Chem.201356239542955510.1021/jm401604x 24195776
    [Google Scholar]
  14. SpicerJ.A. MillerC.K. O’ConnorP.D. Inhibition of the cytolytic protein perforin prevents rejection of transplanted bone marrow stem cells in vivo.J. Med. Chem.20206352229223910.1021/acs.jmedchem.9b00881 31525966
    [Google Scholar]
  15. LyonsD.M. HuttunenK.M. BrowneK.A. Inhibition of the cellular function of perforin by 1-amino-2,4-dicyanopyrido[1,2-a]benzimidazoles.Bioorg. Med. Chem.201119134091410010.1016/j.bmc.2011.05.013 21664824
    [Google Scholar]
  16. MillerC.K. HuttunenK.M. DennyW.A. Diarylthiophenes as inhibitors of the pore-forming protein perforin.Bioorg. Med. Chem. Lett.201626235536010.1016/j.bmcl.2015.12.003 26711151
    [Google Scholar]
  17. LiW. SiH. LiY. 3D-QSAR and molecular docking studies on designing inhibitors of the hepatitis C virus NS5B polymerase.J. Mol. Struct.2016111722723910.1016/j.molstruc.2016.03.073
    [Google Scholar]
  18. TampioJ. Markowicz-PiaseckaM. HuttunenK.M. Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosis.Chem. Biol. Interact.202134510956010.1016/j.cbi.2021.109560 34153225
    [Google Scholar]
/content/journals/cei/10.2174/0115734080298673240424052128
Loading
/content/journals/cei/10.2174/0115734080298673240424052128
Loading

Data & Media loading...


  • Article Type:
    Editorial
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test